Gut dysbiosis in autoimmune diseases: Association with mortality
Frontiers in Cellular and Infection Microbiology · 31.03.2023 · 13
DOI: 10.3389/fcimb.2023.1157918 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 31.03.2023. Verfasst von Sung-Ho Chang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Molecular Microbiology, School of Dentistry and Dental Research Institute, Seoul National University, Seoul, Republic of…. Hauptthemen laut MEDLINE: Autoimmune Diseases, Sjogren's Syndrome, Arthritis, Rheumatoid, Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
To better understand the impact of gut dysbiosis on four autoimmune diseases [Sjögren’s syndrome (SS), systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and multiple sclerosis (MS)], this review investigated the altered gut bacteria in each disease and the shared ones among the four diseases. The enriched gut bacteria shared by three of the four autoimmune diseases were Streptococcus , Prevotella , and Eggerthella , which are associated with autoantibody production or activation of Th17 cells in immune-related diseases. On the other hand, Faecalibacterium comprises depleted gut bacteria shared by patients with SLE, MS, and SS, which is associated with various anti-inflammatory activities. The indexes of gut dysbiosis, defined as the number of altered gut bacterial taxa divided by the number of studies in SLE, MS, RA, and SS, were 1.7, 1.8, 0.7, and 1.3, respectively. Interestingly, these values presented a positive correlation trend with the standardized mortality rates —2.66, 2.89, 1.54, and 1.41, respectively. In addition, shared altered gut bacteria among the autoimmune diseases may correlate with the prevalence of polyautoimmunity in patients with SLE, SS, RA, and MS, that is, 41 percent, 32.6 percent, 14 percent, and 1–16.6 percent, respectively. Overall, this review suggests that gut dysbiosis in autoimmune diseases may be closely related to the failure of the gut immune system to maintain homeostasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Immunology and Molecular Microbiology, School of Dentistry and Dental Research Institute, Seoul National University, Seoul, Republic of Korea.
Förderung
- National Research Foundation of Korea
Zitieren
APA
Chang, S. H., & Choi, Y. (2023). Gut dysbiosis in autoimmune diseases: Association with mortality. Frontiers in Cellular and Infection Microbiology, 13. https://doi.org/10.3389/fcimb.2023.1157918
Vancouver
Chang SH, Choi Y. Gut dysbiosis in autoimmune diseases: Association with mortality. Frontiers in Cellular and Infection Microbiology. 2023;13. doi:10.3389/fcimb.2023.1157918
BibTeX
@article{Chang2023,
author = {Chang, Sung-Ho and Choi, Youngnim},
title = {Gut dysbiosis in autoimmune diseases: Association with mortality},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2023},
volume = {13},
doi = {10.3389/fcimb.2023.1157918}
}
EUVIMED